Stability of Biometry in Meibomian Gland Dysfunction

Status Recruiting

Clinical Trial Summary

Accurate biometry is an essential and indispensable tool in preoperative cataract surgery setting to yield optimal postoperative refractive outcome. However, some recent studies indicate that preoperative biometry is influenced by dry eye disease (DED). Hence, the investigator's study aims to investigate the effect of the therapy of MGD using the Lipiflow® device on the stability of biometry and selection of IOL.

Clinical Trial Description

Accurate biometry is an essential and indispensable tool in preoperative cataract surgery setting to yield optimal postoperative refractive outcome. 31 Patients suffering from DED caused by MGD will be selected and allocated randomly to therapy. Patients with pre-existing DED therapy other than lubricants will be excluded. After completing prestudy-screening and baseline visit, Lipiflow® therapy is applied to the study eye. Follow-up visits will be scheduled two weeks and three months after baseline visit. Each visit includes dry eye investigations and IOL calculation by IOLmaster 700 and CSO MS-39. After each study visit an IOL will be theoretically selected. ;

Study Design

Related Conditions & MeSH terms

Meibomian Gland Dysfunction

Clinical Trial Details

NCT number	NCT04322656
Study type	Interventional
Source	Vienna Institute for Research in Ocular Surgery
Contact	Oliver Findl, Univ.Prof. Dr.
Phone	+43 1 91021-84611
Email	oliver@findl.at
Status	Recruiting
Phase	N/A
Start date	February 6, 2020
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05062564` - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye	N/A
Completed	`NCT04884243` - Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction	Phase 2
Active, not recruiting	`NCT04425551` - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction	N/A
Terminated	`NCT02596919` - Fast Infrared Meibography (Photography)	N/A
Completed	`NCT01207752` - The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction	N/A
Completed	`NCT05162261` - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction	N/A
Recruiting	`NCT06064071` - Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD	N/A
Completed	`NCT03652051` - A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)	Phase 2
Recruiting	`NCT03767530` - Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction	N/A
Active, not recruiting	`NCT05577910` - Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD	N/A
Completed	`NCT04889950` - Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction	N/A
Recruiting	`NCT06004895` - Mechanisms of Light-based Therapies for Dry Eye Disease	N/A
Completed	`NCT04147962` - Intense Pulsed Light in Meibomian Gland Dysfunctions
Completed	`NCT02256969` - Intraductal Meibomian Gland Probing Trial	Phase 4
Recruiting	`NCT05089591` - Intense Pulsed Light in Meibomian Gland Dysfunction	N/A
Completed	`NCT04500821` - Evaluation of the LipiFlow System With a New Activator	N/A
Completed	`NCT03318874` - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction	Phase 4
Completed	`NCT06278584` - iLux Treatment for Meibomian Gland Dysfunction	N/A
Recruiting	`NCT04052841` - Morphological Analysis of Meibomian Glands	N/A
Completed	`NCT05028491` - The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients